Compare FISI & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | FISI | YDES |
|---|---|---|
| Founded | 1817 | 2013 |
| Country | United States | Taiwan |
| Employees | 631 | N/A |
| Industry | Major Banks | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 643.4M | 543.0M |
| IPO Year | N/A | N/A |
| Metric | FISI | YDES |
|---|---|---|
| Price | $34.94 | $5.20 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $37.00 | N/A |
| AVG Volume (30 Days) | ★ 93.1K | 22.7K |
| Earning Date | 04-23-2026 | 04-30-2026 |
| Dividend Yield | ★ 3.70% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.22 | N/A |
| P/E Ratio | $9.36 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $24.41 | $5.00 |
| 52 Week High | $35.67 | $25.00 |
| Indicator | FISI | YDES |
|---|---|---|
| Relative Strength Index (RSI) | 63.95 | 35.34 |
| Support Level | $26.91 | N/A |
| Resistance Level | $35.49 | $13.19 |
| Average True Range (ATR) | 0.80 | 0.56 |
| MACD | -0.01 | 0.03 |
| Stochastic Oscillator | 67.50 | 13.42 |
Financial Institutions Inc operates through its subsidiaries, providing full range of banking services to consumer, commercial and municipal customers in Western and Central New York, and commercial loans in the Mid-Atlantic region, through a loan production office in Ellicott City, Maryland. It offers a broad range of loans including commercial business and revolving lines of credit, commercial mortgages, equipment loans, residential mortgage loans and home equity loans and lines of credit, automobile loans and personal loans. It operates in single segment of Banking.
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.